CYD-4-61 is a novel Bax activator used in breast cancer research; it inhibits proliferation of triple-negative breast cancer MDA-MB-231 and ER-positive breast cancer MCF-7 cell lines; it activates Bax protein to induce cytochrome c release, modulates apoptotic biomarkers, and triggers cancer cell apoptosis.